Dr David Dorward
We study the cellular and molecular mechanisms of disease using state-of-the-art imaging techniques. Our focus is on thoracic disease, specifically acute respiratory distress syndrome (ARDS), Covid-19, and thoracic cancers.
- Naomi Gachanja, PhD student
- Philippe Potey, PhD Student
David's research explores the cellular and molecular mechanisms of disease using a range of techniques, including cutting-edge imaging modalities, in two main areas: (i) macrophage and epithelial cell function in acute lung injury and (ii) Immune cell polarisation and engagement in the tumour microenvironment of thoracic cancers. David is Principal Investigator of the ICECAP consortium (Inflammation in COVID-19 – Exploration of Critical Aspects of Pathogenesis) a rapid response team investigating the key features of Covid-19.
David Dorward graduated with first class honours in pathology in 2003 and in medicine with honours in 2006. He trained in respiratory medicine for 6 years before starting a PhD, which he completed in 2014. He then trained in pathology with a special interest in respiratory disease and critical illness.
Honorary Consultant Pathologist, Royal Infirmary of Edinburgh
- Professor Adriano Rossi (University of Edinburgh)
- Dr Christopher Lucas (University of Edinburgh)
- Professor Kev Dhaliwal (University of Edinburgh)
- Dr Kenneth Baillie (University of Edinburgh)
- Professor David Harrison (University of St Andrews)
Sources of Funding
- The Pathological Society
- Chief Scientist Office
- Medical Research Scotland
- UK Research and Innovation